RECRUITING

Enhancing Triadic Communication About Cognition for Older Adults With Alzheimer's Disease or Related Dementias Facing a Cancer Management Decision

Conditions

Study Overview

This clinical trial focuses on testing the efficacy of different digital interventions to promote re-engagement in cancer-related long-term follow-up care for adolescent and young adult (AYA) survivors of childhood cancer.

Description

Building upon prior work, the investigator team developed a communication intervention for older adults with ADRD who are considering a decision about cancer management (adapted intervention: COACH-Cog). The investigators hypothesize that for patients with dual diagnoses of ADRD and cancer, COACH-Cog will increase autonomy support of care partners and patients in the decision-making process, leading to greater acknowledgement and support of cognitive concerns and cognitive-related goals, thereby improving goal concordant care. The investigators are conducting a pilot randomized controlled trial (RCT; cluster randomized by physician) including approximately 45 oncology clinicians and 130 patient/care partner dyads evaluating the effect of COACH-Cog on care partner and patient autonomy support, care partner well-being, goal-concordance, and communication.

Official Title

Enhancing Triadic Communication About Cognition for Older Adults With Alzheimer's Disease or Related Dementias Facing a Cancer Management Decision

Quick Facts

Study Start:2024-04-22
Study Completion:2027-10
Study Type:Not specified
Phase:Not Applicable
Enrollment:Not specified
Status:RECRUITING

Study ID

NCT06313853

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Ages Eligible for Study:65 Years
Sexes Eligible for Study:ALL
Accepts Healthy Volunteers:No
Standard Ages:OLDER_ADULT
Inclusion CriteriaExclusion Criteria
  1. 1. Be age 65 or older
  2. 2. Have a clinical diagnosis of Alzheimer's disease or related dementia (ADRD \[Alzheimer's disease, vascular dementia, Lewy body dementia, frontotemporal dementia, or dementia of unknown subtype\])
  3. 3. Have a clinical diagnosis of cancer (any type or stage)
  4. 4. Anticipate a potential decision about cancer-related management, as confirmed by the patient's primary medical oncology clinician.
  5. 5. Have a care partner willing and able to participate in the study
  6. 6. Are able to read and understand English. The communication coaching session will be delivered in English, thus necessitating this requirement.
  7. 7. Be able to provide informed consent (as measured by UBACC) or have a Legally Authorized Representative to provide informed consent
  1. Pregnancy or breastfeeding
  2. Severe psychiatric disorders
  3. Active substance abuse
  4. Unstable medical conditions
  5. Inability to comply with study requirements

Contacts and Locations

Study Contact

Allison Magnuson
CONTACT
585-602-5085
allison_magnuson@urmc.rochester.edu
Jessica Bauer
CONTACT
585-602-5085
JessicaC_Bauer@URMC.Rochester.edu

Principal Investigator

Allison Magnuson
PRINCIPAL_INVESTIGATOR
University of Rochester

Study Locations (Sites)

University of Rochester Wilmot Cancer Institute
Rochester, New York, 14620
United States

Collaborators and Investigators

Sponsor: University of Rochester

  • Allison Magnuson, PRINCIPAL_INVESTIGATOR, University of Rochester

Study Record Dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Registration Dates

Study Start Date2024-04-22
Study Completion Date2027-10

Study Record Updates

Study Start Date2024-04-22
Study Completion Date2027-10

Terms related to this study

Additional Relevant MeSH Terms

  • Cancer
  • Dementia